Ready to contact us for a consultation about your condition and our medical services? The staff of our Global Patient Services is ready to help. Please select the appropriate button to get started.

Now at Sheba – Revolutionary SRT-100 Vision System from Sensus Healthcare

SRT-100 Vision
Sensus Healthcare recently sent its SRT-100 Vision system to Sheba Medical Center. This advanced device uses Image-Guided Superficial Radiation Therapy (IGSRT) to enable the non-invasive treatment of non-melanoma skin cancers (NMSC). The new SRT-100 Vision system unit is the third of its kind in Israel, with the other two installed previously at Ichilov Hospital in Tel Aviv and Beilinson Hospital in Petah Tikva.

“Having the SRT-100 Vision system at Sheba Medical Center, the largest hospital in the country and a significant member of the global medical community, furthers Sensus’s mission to make this breakthrough treatment available around the world,” said Joe Sardano, CEO of Sensus Healthcare.

The SRT-100 Vision system evaluates basal and squamous cell carcinomas and keloid tissue with targeted and precise treatment. Also, the LesionCam records each session, which enables doctors to closely track any changes in the lesion and customize treatment accordingly.

Sensus recently opened a new office in Tel Aviv – thereby expanding its footprint in the region. As the company’s business in Israel grows, they are tapping into the country’s innovative skills as well as meeting increased patient demand for a painless, non-invasive option for non-melanoma skin cancer and keloid treatment. Thousands of patients have already benefited from Sensus’s safe and effective technology, and Sheba Medical Center is pleased to make this treatment available to even more people.

SRT-100 Vision available at Sheba Medical Center in Israel
Sheba Leverages ChatGPT
Accelerating Diagnostics: ChatGPT Results Aligned with Breast Cancer Board Recommendations
Recently, several distinguished Sheba clinicians were impressed by the tool’s capabilities. The group, which included Dr. Vera Sorin, Dr. Eyal Klang, Dr. Miri Sklair-Levy, Prof.…
Read More
Sheba and Vidac
Novel Drug Set to Improve CAR T-Cell Therapy Effectiveness
While many medical centers around the world depend on external labs to genetically engineer patient T-cells, a process that can take up to a few…
Read More
Sheba Named Global Oncology Leader
by Newsweek Magazine
Dedicated to providing those in need across the globe ‘Hope Without Boundaries,’ Sheba treats patients from more than 100 countries each year, employing the latest…
Read More